Immunocore Holdings Plc Sponsored ADR IMCR 深 沪
已收盘 12-12 16:00:00 美东时间
36.80
+1.000
+2.79%
华盛通- 最 高36.94
- 今 开35.99
- 成交量 44.13万股
- 最 低 35.4834
- 昨 收 35.80
- 总市值 18.54亿
- 52周最高 40.7147
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.15
- 委 比 -99.46%
- 总股本 5038.71万
- 历史最高 76.98
- 量 比 1.51
- 振 幅 4.07%
- 历史最低 18.43
- 每 手 1
- 风险率 3.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immunocore Holdings Board Member Ranjeev Krishana Resigns
The latest announcement is out from Immunocore Holdings ( ($IMCR) ). On Novembe...
11-28 20:28
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
Morgan Stanley Maintains Equal-Weight on Immunocore Holdings, Raises Price Target to $36
Morgan Stanley analyst Andrew Galler maintains Immunocore Holdings (NASDAQ:IMCR) with a Equal-Weight and raises the price target from $34 to $36.
11-11 01:54
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc announced its participation in two healthcare conferences in November 2025. The Guggenheim 2nd Annual Healthcare Innovation Conference will feature a fireside chat on November 11, 2025, at 3:00 p.m. EST. Additionally, Immunocore will participate in the Jefferies London Healthcare Conference with a fireside chat on November 19, 2025, at 3:30 p.m. GMT. Presentations will be available live via webcast and on Immunocore’s webs...
11-10 12:00
Immunocore Hldgs Q3 Sales $103.693M Beat $100.186M Estimate
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly sales of $103.693 million which beat the analyst consensus estimate of $100.186 million by 3.50 percent. This is a 29.22 percent increase over sales of $80.248 million
11-06 20:28
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Wells Fargo Initiates Coverage On Immunocore Holdings with Overweight Rating, Announces Price Target of $60
Wells Fargo analyst Eva Fortea Verdejo initiates coverage on Immunocore Holdings (NASDAQ:IMCR) with a Overweight rating and announces Price Target of $60.
11-01 05:02
华尔街顶级分析师最新评级：苹果获上调，康卡斯特遭下调
华尔街最受关注、且可能影响市场走势的研究评级报告现已汇总。以下是由 The Fly 整理的今日投资者需重点关注的分析师评级变动信息。 五大评级上调案例： ...
10-31 22:42
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.
10-23 01:36
